title: Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis.
abstract: IgG4-related disease is a recently recognized multi-organ disorder characterized by high levels of serum IgG4 and dense infiltration of IgG4-positive cells into several organs. Although the pancreas was the first organ recognized to be affected by IgG4-related disorder in the syndrome of autoimmune pancreatitis, we present here clinico-pathological features of 23 patients diagnosed as having renal parenchymal lesions. These injuries were associated with a high level of serum IgG4 and abundant IgG4-positive plasma cell infiltration into the renal interstitium with fibrosis. In all patients, tubulointerstitial nephritis was the major finding. Although 14 of the 23 patients did not have any pancreatic lesions, their clinicopathological features were quite uniform and similar to those shown in autoimmune pancreatitis. These included predominance in middle-aged to elderly men, frequent association with IgG4-related conditions in other organs, high levels of serum IgG and IgG4, a high frequency of hypocomplementemia, a high serum IgE level, a patchy and diffuse lesion distribution, a swirling fibrosis in the renal pathology, and a good response to corticosteroids. Thus, we suggest that renal parenchymal lesions actually develop in association with IgG4-related disease, for which we propose the term 'IgG4-related tubulointerstitial nephritis.'
authors: Department of Internal Medicine, Nagaoka Red Cross Hospital, Nagaoka, Niigata, Japan. saekit@nagaoka.jrc.or.jp
authors: Takako
authors: T
authors: Saeki
authors: Shinichi
authors: S
authors: Nishi
authors: Naofumi
authors: N
authors: Imai
authors: Tomoyuki
authors: T
authors: Ito
authors: Hajime
authors: H
authors: Yamazaki
authors: Mitsuhiro
authors: M
authors: Kawano
authors: Motohisa
authors: M
authors: Yamamoto
authors: Hiroki
authors: H
authors: Takahashi
authors: Shoko
authors: S
authors: Matsui
authors: Shinji
authors: S
authors: Nakada
authors: Tomoki
authors: T
authors: Origuchi
authors: Akira
authors: A
authors: Hirabayashi
authors: Noriyuki
authors: N
authors: Homma
authors: Yutaka
authors: Y
authors: Tsubata
authors: Takuma
authors: T
authors: Takata
authors: Yoko
authors: Y
authors: Wada
authors: Akihiko
authors: A
authors: Saito
authors: Sachiko
authors: S
authors: Fukase
authors: Kunihiro
authors: K
authors: Ishioka
authors: Kana
authors: K
authors: Miyazaki
authors: Yasufumi
authors: Y
authors: Masaki
authors: Hisanori
authors: H
authors: Umehara
authors: Susumu
authors: S
authors: Sugai
authors: Ichiei
authors: I
authors: Narita
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000936:Antigen-Antibody Complex / Q000378:metabolism; D001327:Autoimmune Diseases / Q000276:immunology / Q000473:pathology; D001706:Biopsy; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007073:Immunoglobulin E / Q000378:metabolism; D007074:Immunoglobulin G / Q000378:metabolism*; D007668:Kidney / Q000276:immunology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009395:Nephritis, Interstitial / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology*; D010195:Pancreatitis / Q000276:immunology / Q000473:pathology; D010950:Plasma Cells / Q000276:immunology* / Q000473:pathology*; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies
chemical_list: D000936:Antigen-Antibody Complex; D005938:Glucocorticoids; D007074:Immunoglobulin G; D007073:Immunoglobulin E; D011239:Prednisolone